In May 2016 Ethicon, a Johnson & Johnson subsidiary, issued a market withdrawal of their Physiomesh flexible composite hernia mesh product. The market withdrawal is a result of studies that highlighted increased revision rates and complications after some minimally invasive hernia repair surgeries.
In a correspondence sent to healthcare professionals and providers, Ethicon stated that they would be voluntarily recalling their Physiomesh flexible composite in response to unpublished data they reviewed from two European hernia registries. The data showed a discrepancy between the Physiomesh flexible composite and other meshes in the registries following laparoscopic ventral hernia repair.
Ethicon describes their recall as a voluntary withdrawal of from the market. They announced the market withdrawal with the issuance of their May 2016 “URGENT FIELD SAFETY NOTICE”. Currently there are a number of Physiomesh cases filed against Ethicon in Federal court nationwide. Similarly, Ethicon continues to battle lawsuits nationwide against their transvaginal mesh products. Like Physiomesh, Ethicon’s transvaginal mesh products are produced with polypropylene and have been associated with a higher risk for complications.